Money

Markets, macro, business, and personal finance developments.

All Markets Economy Business Crypto Energy

Briefing: Trump reportedly wants to 'take the oil in Iran' as Tehran targets water, power plants in Kuwait

Strategic angle: The Middle East conflict has entered its fifth week, with attacks expanding across the region and raising risks to energy and infrastructure.

Editorial Staff Mar 30

Money

Briefing: Yen strengthens after Japan official warns of ‘decisive action’

Strategic angle: Traders have also speculated that government may intervene in crude oil markets.

Editorial Staff Mar 30

Money

CL.1 | Crude Oil WTI (NYM $/bbl) Front Month Overview

MarketWatch provides an overview of the current WTI crude oil prices.

Editorial Staff Mar 30

Money

Briefing: China cracks down on ‘bone ash’ burials in empty apartments

Strategic angle: Younger tenants do not mind dead neighbours if it drives down rents in a building

Editorial Staff Mar 30

Money

Briefing: Oil price rises past $116 as Iran conflict worsens

Strategic angle: Prices for Brent crude rise 3 per cent during early trading in Asia

Editorial Staff Mar 30

Money

Briefing: South Korea stocks fall 5%, leading regional declines as Middle East war enters fifth week

Strategic angle: Asia-Pacific markets fell Monday as the Middle East war enters its fifth week.

Editorial Staff Mar 30

Money

Briefing: Pro-AI group to spend $100mn on US midterm elections as backlash grows

Strategic angle: November 8 poll set to be battleground over regulation of AI

Editorial Staff Mar 30

Money

Briefing: Wall Street Expected Micron to Stumble. Here's Why the Bears Could Be Dead Wrong.

Strategic angle: Analysts are reconsidering their bearish outlook on Micron amid changing market dynamics.

Editorial Staff Mar 29

Money

Briefing: Prediction: This Will Be Palantir's Stock Price in 2030

Strategic angle: Experts weigh in on the future valuation of Palantir Technologies.

Editorial Staff Mar 29

Money

Briefing: How to get a business loan

Strategic angle: Essential steps and tips for securing a business loan.

Editorial Staff Mar 29

Money

Briefing: HCICR Stock Price | Hennessy Capital Investment Corp. VIII Rt Stock Quote (U.S.: Nasdaq)

Strategic angle: Latest updates on Hennessy Capital Investment Corp. VIII stock performance.

Editorial Staff Mar 29

Money

Briefing: Why Rocket Pharmaceuticals (RCKT) Got a Commercial Boost From FDA Approval of KRESLADI

Strategic angle: Rocket Pharmaceuticals sees a significant commercial advantage following the FDA's approval of KRESLADI.

Editorial Staff Mar 29

Money

Briefing: How Datavault AI (DVLT) Reached Its First Profitable Quarter and Set a 2026 Growth Target

Strategic angle: Datavault AI achieves profitability and outlines ambitious growth plans for the future.

Editorial Staff Mar 29

Money

Briefing: Why Vertical Aerospace (EVTL) Is Expanding Its Valo Supplier Network Ahead of Certification

Strategic angle: Vertical Aerospace is strategically expanding its supplier network to enhance its certification process.

Editorial Staff Mar 29

Money

Briefing: Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab

Strategic angle: UBS maintains a neutral stance on Jasper Therapeutics despite advancements in their Briquilimab treatment.

Editorial Staff Mar 29

Money

Briefing: AACPU | Apogee Acquisition Corp. Annual Income Statement

Strategic angle: Explore the annual income statement of Apogee Acquisition Corp. on MarketWatch.

Editorial Staff Mar 29

Money

Briefing: Why Rezolve AI (RZLV) Is Betting Big on Reward Loyalty to Scale Commerce Media and Payments

Strategic angle: Exploring Rezolve AI's strategy to leverage reward loyalty in the commerce media and payments sector.

Editorial Staff Mar 29

Money

Briefing: Why agilon health (AGL) Is Doing a 1-for-25 Reverse Split to Stay NYSE-Compliant

Strategic angle: agilon health (AGL) announces a reverse stock split to maintain compliance with NYSE listing requirements.

Editorial Staff Mar 29

Money

Briefing: Why Allogene Therapeutics (ALLO) Says Its Lead Cancer Program Is Still on Track in 2026

Strategic angle: Allogene Therapeutics reassures investors about the progress of its lead cancer program.

Editorial Staff Mar 29

Money

Briefing: Why the SaaS Sell-Off Is Creating Generational Buying Opportunities

Strategic angle: The recent decline in SaaS stocks presents unique investment opportunities for savvy investors.

Editorial Staff Mar 29